Bausch Health Companies (BHC) Retained Earnings (2009 - 2026)
Bausch Health Companies (BHC) posted Retained Earnings of -$10.8 billion for Q2 2026, up 2.33% sequentially from -$11.1 billion in Q1 2026, and down 11.28% YoY from -$12.2 billion in Q2 2025.
Bausch Health Companies (BHC) Retained Earnings (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Retained Earnings for 18 years, with the latest figure at -$10.8 billion in Q2 2026.
- Quarterly Retained Earnings fell 11.28% year-over-year to -$10.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$10.8 billion (down 11.28% YoY) and the FY2025 annual result came in at -$9.7 billion, up 1.6% from the prior year.
- Retained Earnings advanced to -$10.8 billion in Q2 2026 per BHC's latest filing, from -$11.1 billion in the prior quarter.
- Over five years, Retained Earnings peaked at -$8.8 billion in Q3 2022 and troughed at -$11.1 billion in Q1 2026.
- A 5-year average of -$9.7 billion and a median of -$9.7 billion in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings increased 3.65% in 2025, then dropped 12.22% in 2026.
- Over 5 years, Retained Earnings stood at -$9.2 billion in 2022, then dropped by 6.44% to -$9.8 billion in 2023, then decreased by 0.47% to -$9.8 billion in 2024, then grew by 1.6% to -$9.7 billion in 2025, then fell by 12.05% to -$10.8 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$10.8 billion, -$11.1 billion, and -$9.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.42 Bn | 43.46 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.71 Bn | 40.06 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.56 Bn | 30.88 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.41 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | 3.75 Bn |
| 10 | Bausch Health Companies | 2.54 Bn | 700.75 Mn | 2.10 Bn | -10.83 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.83 Bn |
| Mar 31, 2026 | -11.09 Bn |
| Dec 31, 2025 | -9.67 Bn |
| Sep 30, 2025 | -1.80 Bn |
| Jun 30, 2025 | -1.79 Bn |
| Mar 31, 2025 | -2.03 Bn |
| Dec 31, 2024 | -9.82 Bn |
| Sep 30, 2024 | -9.92 Bn |
| Jun 30, 2024 | -9.83 Bn |
| Mar 31, 2024 | -9.84 Bn |
| Dec 31, 2023 | -9.78 Bn |
| Sep 30, 2023 | -2.05 Bn |
| Jun 30, 2023 | -9.36 Bn |
| Mar 31, 2023 | -9.39 Bn |
| Dec 31, 2022 | -9.19 Bn |
| Sep 30, 2022 | -2.27 Bn |
| Jun 30, 2022 | -9.18 Bn |
| Mar 31, 2022 | -9.03 Bn |
| Dec 31, 2021 | -8.96 Bn |
| Sep 30, 2021 | -9.03 Bn |